Home

About

For Patients

For Referrers

For Patients 

For Medical/Health Professionals

Blog

Contact

Footer Navigation

Recent updates to colorectal cancer screening guidelines in Australia have introduced significant changes to the recommended starting age for faecal occult blood testing (FOBT). As of July 1, 2024, the National Bowel Cancer Screening Program lowered the eligibility age for free, at-home FOBT from 50 to 45 years. This means that individuals aged 45 to 74 are now encouraged to participate in biennial (every two years) screening

 The recommended age to begin FOBT screening is now 45 years for individuals at average risk of bowel cancer

 Eligible individuals should complete the free, at-home FOBT every two years.

 Those aged 50 to 74 will continue to receive test kits by mail. Individuals aged 45 to 49 can request their first kit online or by calling the National Cancer Screening Register

These changes aim to enhance early detection of bowel cancer, improving treatment outcomes. It's important to note that individuals with a family history of bowel cancer or other risk factors may need to start screening earlier or undergo more frequent testing.

Updates to colorectal cancer screening guidelines

Understanding Diagnosis and Collaboration with Gastroenterologists

SIBO is a complex gastrointestinal disorder characterized by an excessive growth of bacteria in the small intestine, leading to various symptoms and potential complications. In this blog post, we will explore the essentials of SIBO, its diagnosis, and the importance of collaboration with gastroenterologists for effective management.

What is Small Intestinal Bacterial Overgrowth (SIBO)?

Small Intestinal Bacterial Overgrowth (SIBO) occurs when there is an abnormal proliferation of bacteria in the small intestine, where bacterial concentrations are typically lower than in the colon. This overgrowth can interfere with normal digestive processes and nutrient absorption, resulting in symptoms such as:

Abdominal bloating: Often accompanied by discomfort or pain.

Diarrhoea: Sometimes alternating with constipation.

Nutritional deficiencies: Due to malabsorption of essential nutrients like vitamin B12 and iron.

Fatigue: Resulting from nutrient deficiencies and systemic effects of bacterial metabolites.

Several factors can contribute to the development of SIBO

Impaired gut motility: Conditions such as intestinal strictures, adhesions, or disorders affecting peristalsis.

Anatomical abnormalities: Diverticula or blind loops in the intestine.

Medications: Proton pump inhibitors (PPIs), opioids, and antibiotics that alter gut flora balance.

Underlying gastrointestinal disorders: such as Crohn's disease, coeliac disease, or gastroparesis.

Previous gastrointestinal surgery: Which can disrupt normal gut anatomy.

Recognising the signs and symptoms of SIBO is crucial for prompt diagnosis and intervention. Diagnostic approaches typically include:

Clinical Assessment: Thorough history-taking and physical examination to identify symptoms suggestive of SIBO.

Breath Testing: Hydrogen or methane breath tests following ingestion of a substrate (e.g., lactulose or glucose) to detect elevated gas production by bacteria in the small intestine.

Small Bowel Aspiration: Invasive procedure; rarely performed but may be indicated in certain clinical scenarios.

Management of SIBO focuses on reducing bacterial overgrowth, alleviating symptoms, and addressing underlying contributing factors. Treatment options may include:

Antibiotic Therapy: Targeted antibiotics such as rifaximin or combination therapy to eradicate bacterial overgrowth.

Probiotics: Some probiotic strains may help restore a healthy gut microbiota balance.

Dietary Modifications: Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) diet to reduce gas-producing substrates.

Nutritional Support: Addressing nutrient deficiencies, particularly vitamin B12 and iron supplementation.

Management of Underlying Conditions: Treating any underlying gastrointestinal disorders contributing to SIBO.

Collaborative Care with Gastroenterologists

Collaboration with gastroenterologists is essential for confirming the diagnosis of SIBO and establishing a comprehensive treatment plan. Gastroenterologists can offer:

Expertise in Gastrointestinal Disorders: Specialised knowledge and experience in diagnosing and managing SIBO and other complex digestive conditions.

Advanced Diagnostic Tools: Access to advanced diagnostic tests such as small bowel imaging and endoscopy to evaluate for structural abnormalities contributing to SIBO.

Tailored Treatment Plans: Individualised treatment strategies based on the severity of symptoms, underlying conditions, and patient-specific factors.

Long-Term Management: Ongoing monitoring and adjustments to treatment to optimise patient outcomes and minimise recurrence of symptoms.

Educating patients about SIBO, its potential causes, and the importance of adherence to treatment protocols is essential for successful management. Follow-up assessments and monitoring can help evaluate treatment effectiveness, adjust therapy as needed, and address any recurrent symptoms or complications.

By enhancing healthcare professional’s understanding of Small Intestinal Bacterial Overgrowth (SIBO) and collaborating closely with gastroenterologists, we can ensure timely diagnosis, effective management, and improved quality of life for patients experiencing gastrointestinal symptoms. Together, we can provide comprehensive care and support to address the complex challenges associated with SIBO and other digestive disorders.

Our team is dedicated to providing expert care and support for patients with complex gastrointestinal conditions.

For Medical/Health Professionals

Blog for Professionals

Updates to colorectal cancer screening guidelines

Small Intestinal Bacterial Overgrowth (SIBO)

Request an Appointment